Windtree Therapeutics Inc expected to post a loss of 94 cents a share - Earnings Preview

Windtree Therapeutics

27/03/2024 20:10

* Windtree Therapeutics Inc  WINT.OQ   WINT.O  is expected
to report resultson March 29 (estimated) for the period ending
December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Windtree Therapeutics
Inc is
for a loss of 94 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Windtree
Therapeutics Inc is $3.00​, above​ its last closing price
of $0.35. ​​​

This summary was machine generated March 27 at 20:10 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)